Healthcare Realty Trust’s (HR) Outperform Rating Reaffirmed at Wedbush

Healthcare Realty Trust (NYSE:HR)‘s stock had its “outperform” rating reissued by investment analysts at Wedbush in a research note issued to investors on Thursday,RTT News reports. They presently have a $16.00 price target on the real estate investment trust’s stock. Wedbush’s price target points to a potential downside of 3.59% from the stock’s current price.

Several other analysts have also recently weighed in on HR. JPMorgan Chase & Co. cut Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research report on Friday, December 20th. Jefferies Financial Group lowered Healthcare Realty Trust from a “buy” rating to a “hold” rating and dropped their price target for the company from $19.00 to $17.00 in a research report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.00.

Healthcare Realty Trust Trading Down 1.0 %

NYSE HR traded down $0.18 on Thursday, hitting $16.60. The company’s stock had a trading volume of 3,179,164 shares, compared to its average volume of 2,426,320. The firm has a market cap of $5.88 billion, a P/E ratio of -10.50 and a beta of 0.94. Healthcare Realty Trust has a 52-week low of $12.77 and a 52-week high of $18.90. The company’s 50-day simple moving average is $16.68 and its 200 day simple moving average is $17.42.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. The company had revenue of $309.77 million during the quarter, compared to analyst estimates of $303.81 million. Healthcare Realty Trust had a negative return on equity of 9.42% and a negative net margin of 45.63%. The firm’s revenue was down 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.39 earnings per share. On average, research analysts forecast that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Insiders Place Their Bets

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 7,750 shares of the business’s stock in a transaction on Friday, November 22nd. The shares were acquired at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the purchase, the director now owns 50,002 shares in the company, valued at approximately $869,534.78. This trade represents a 18.34 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Robert E. Hull sold 10,000 shares of the business’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total value of $174,800.00. Following the completion of the transaction, the chief operating officer now owns 171,400 shares of the company’s stock, valued at $2,996,072. This represents a 5.51 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have purchased 18,750 shares of company stock valued at $323,723. 0.56% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Healthcare Realty Trust

Several large investors have recently bought and sold shares of the business. Mackenzie Financial Corp boosted its holdings in shares of Healthcare Realty Trust by 234.9% during the 4th quarter. Mackenzie Financial Corp now owns 56,987 shares of the real estate investment trust’s stock valued at $966,000 after acquiring an additional 39,969 shares during the last quarter. GF Fund Management CO. LTD. purchased a new stake in Healthcare Realty Trust in the fourth quarter worth approximately $112,000. Sophron Capital Management L.P. purchased a new stake in Healthcare Realty Trust in the fourth quarter worth approximately $3,192,000. Starboard Value LP bought a new stake in Healthcare Realty Trust in the 4th quarter worth approximately $342,110,000. Finally, Safe Harbor Fiduciary LLC raised its stake in Healthcare Realty Trust by 4.2% during the 4th quarter. Safe Harbor Fiduciary LLC now owns 24,365 shares of the real estate investment trust’s stock valued at $413,000 after buying an additional 975 shares during the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.